Vanda Pharmaceuticals Inc. Quarterly Costs and Expenses in USD from Q2 2010 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Total costs of sales and operating expenses for the period.
Summary
Vanda Pharmaceuticals Inc. quarterly/annual Costs and Expenses history and growth rate from Q2 2010 to Q2 2024.
  • Vanda Pharmaceuticals Inc. Costs and Expenses for the quarter ending June 30, 2024 was $60.6M, a 23.9% increase year-over-year.
  • Vanda Pharmaceuticals Inc. Costs and Expenses for the twelve months ending June 30, 2024 was $214M, a 6.2% decline year-over-year.
  • Vanda Pharmaceuticals Inc. annual Costs and Expenses for 2023 was $207M, a 16.7% decline from 2022.
  • Vanda Pharmaceuticals Inc. annual Costs and Expenses for 2022 was $248M, a 9.51% increase from 2021.
  • Vanda Pharmaceuticals Inc. annual Costs and Expenses for 2021 was $227M, a 2.53% increase from 2020.
Costs and Expenses, Trailing 12 Months (USD)
Costs and Expenses, Quarterly (USD)
Costs and Expenses, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 $214M $60.6M +$11.7M +23.9% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-01
Q1 2024 $203M $56.7M -$3.8M -6.28% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-09
Q4 2023 $207M $52.4M -$5.49M -9.49% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-08
Q3 2023 $212M $44.8M -$16.6M -27% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-09
Q2 2023 $229M $48.9M -$12M -19.7% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-01
Q1 2023 $241M $60.5M -$7.37M -10.9% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-09
Q4 2022 $248M $57.9M -$1.53M -2.58% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-08
Q3 2022 $250M $61.4M +$2.13M +3.6% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-09
Q2 2022 $247M $60.9M +$5.4M +9.72% Apr 1, 2022 Jun 30, 2022 10-Q 2023-07-28
Q1 2022 $242M $67.9M +$15.5M +29.7% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-03
Q4 2021 $227M $59.4M +$2.18M +3.81% Oct 1, 2021 Dec 31, 2021 10-K 2024-02-08
Q3 2021 $224M $59.3M +$6.71M +12.8% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-03
Q2 2021 $218M $55.5M +$2.49M +4.7% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-04
Q1 2021 $215M $52.3M -$5.8M -9.97% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-06
Q4 2020 $221M $57.2M +$515K +0.91% Oct 1, 2020 Dec 31, 2020 10-K 2023-02-09
Q3 2020 $220M $52.6M +$3.84M +7.88% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-04
Q2 2020 $217M $53M +$3.87M +7.87% Apr 1, 2020 Jun 30, 2020 10-Q 2021-07-29
Q1 2020 $213M $58.1M +$8.33M +16.7% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-06
Q4 2019 $204M $56.7M +$12.8M +29.2% Oct 1, 2019 Dec 31, 2019 10-K 2022-02-24
Q3 2019 $192M $48.7M +$5.82M +13.6% Jul 1, 2019 Sep 30, 2019 10-Q 2020-10-29
Q2 2019 $186M $49.2M +$5.73M +13.2% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-06
Q1 2019 $180M $49.8M +$8.65M +21% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-07
Q4 2018 $171M $43.9M -$2.54M -5.46% Oct 1, 2018 Dec 31, 2018 10-K 2021-02-11
Q3 2018 $174M $42.9M -$3.36M -7.26% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-07
Q2 2018 $177M $43.4M -$543K -1.24% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-01
Q1 2018 $178M $41.2M -$4.17M -9.2% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-03
Q4 2017 $182M $46.4M +$7.53M +19.4% Oct 1, 2017 Dec 31, 2017 10-K 2020-02-26
Q3 2017 $174M $46.3M +$7.12M +18.2% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-07
Q2 2017 $167M $44M +$3.16M +7.75% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-02
Q1 2017 $164M $45.3M -$416K -0.91% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-02
Q4 2016 $165M $38.9M -$7.84M -16.8% Oct 1, 2016 Dec 31, 2016 10-K 2019-02-19
Q3 2016 $172M $39.1M +$1.25M +3.3% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-08
Q2 2016 $171M $40.8M +$7.78M +23.5% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-03
Q1 2016 $163M $45.7M +$13.3M +41% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-03
Q4 2015 $150M $46.7M +$101M Oct 1, 2015 Dec 31, 2015 10-K 2018-02-15
Q3 2015 $49M $37.9M +$21.7M +133% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-03
Q2 2015 $27.4M $33M +$572K +1.76% Apr 1, 2015 Jun 30, 2015 10-Q 2016-07-28
Q1 2015 $26.8M $32.4M -$3.28M -9.18% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-05
Q4 2014 $30.1M -$54.3M -$70.9M -428% Oct 1, 2014 Dec 31, 2014 10-K 2017-02-17
Q3 2014 $101M $16.2M +$2.09M +14.8% Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-04
Q2 2014 $98.9M $32.5M +$20.7M +177% Apr 1, 2014 Jun 30, 2014 10-Q 2015-07-31
Q1 2014 $78.2M $35.7M +$23.1M +183% Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-07
Q4 2013 $55.1M $16.6M +$1.27M +8.32% Oct 1, 2013 Dec 31, 2013 10-K 2016-02-12
Q3 2013 $53.8M $14.1M +$457K +3.34% Jul 1, 2013 Sep 30, 2013 10-Q 2014-10-27
Q2 2013 $53.3M $11.7M -$4.73M -28.7% Apr 1, 2013 Jun 30, 2013 10-Q 2014-08-08
Q1 2013 $58.1M $12.6M -$3.83M -23.2% Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-08
Q4 2012 $61.9M $15.3M +$1.02M +7.17% Oct 1, 2012 Dec 31, 2012 10-K 2015-03-13
Q3 2012 $60.9M $13.7M +$2.42M +21.5% Jul 1, 2012 Sep 30, 2012 10-Q 2013-11-08
Q2 2012 $58.5M $16.5M +$7.52M +84.1% Apr 1, 2012 Jun 30, 2012 10-Q 2013-07-31
Q1 2012 $50.9M $16.5M +$8.96M +120% Jan 1, 2012 Mar 31, 2012 10-Q 2013-05-10
Q4 2011 $42M $14.3M Oct 1, 2011 Dec 31, 2011 10-K 2014-02-25
Q3 2011 $11.3M +$4.76M +73.2% Jul 1, 2011 Sep 30, 2011 10-Q 2012-11-08
Q2 2011 $8.94M +$1.81M +25.4% Apr 1, 2011 Jun 30, 2011 10-Q 2012-08-03
Q1 2011 $7.49M Jan 1, 2011 Mar 31, 2011 10-Q 2012-05-09
Q3 2010 $6.5M Jul 1, 2010 Sep 30, 2010 10-Q 2011-11-07
Q2 2010 $7.13M Apr 1, 2010 Jun 30, 2010 10-Q 2011-08-05
* An asterisk sign (*) next to the value indicates that the value is likely invalid.